内分泌学とメタボリックシンドローム
オープンアクセス

概要

Efficacy of hydroxychloroquine in patients with Type 2 Diabetes Mellitus (T2DM) inadequately controlled on triple drug therapy as an add‐on

Shaibal Guha

Aim: To evaluate the efficacy of hydroxychloroquine 400mg as a fourth therapeutic agent in type 2 diabetes mellitus (T2DM) patients with poorly controlled blood glucose despite receiving an optimum dose of three oral anti-diabetic drugs (OAD).

Methods: Patients treated with hydroxychloroquine 400 mg as an add-on drug, on those patients who were poorly controlled despite optimum doses of three OADs, metformin, sulfonylureas, pioglitazone or alpha-glucosidase inhibitors were included in this analysis. Total 131 patients with ≥ 3 regular follow-ups visiting a Diabetes Specialty Clinic in Patna Bihar India were considered for this retrospective analysis. All patients were tested to exclude any degree of retinal abnormality or retinopathy or any type of cardiovascular complication before addition of hydroxychloroquine.

Results: Mean age of the patients included was 55.2 ± 9.58 years, with 71 (54.2%) were males. Patients were having ≥60 Kg body weight and 80 (61%) had T2DM for ≥5 yrs. Patients achieving glycemic control (HbA1c≤ 7%) with the addition of hydroxychloroquine were 120 (91.6%)% (P<0.05). The mean duration required to achieve glycemic control after adding hydroxychloroquine was 2.8 months. The mean HbA1c reduced significantly by 1.31 ± 0.5% from the baseline of 7.96 ± 0.5 to 6.65 ± 0.5% (P= 0.001). The fasting blood glucose was reduced from 158.3 ± 27.4 to 114.8 ± 11.2 mg/dl (mean difference: -43.5 ± 14.6 mg/ dl; P=0.001). Whereas the post prandial blood glucose was reduced from 226.9 ± 23.8 to 158.6 ± 22.6 mg/dl (mean difference: -68.3 ± 21.4 mg/dl; P=0.001). The response in age group <55 years was 90.6%, whereas in ≥55 years group, it was 82.1%. Patients with <5 years duration of diabetes responded more (91.8%) compared to patients with a longer duration (≥ 5 years) of diabetes (83.4%).

Conclusion: When type 2 diabetes is uncontrolled by using three oral anti- diabetic drugs adding hydroxychloroquine as a fourth addon therapeutic agent is effective in achieving the desired glycemic control.